Sutro Biopharma Inc. filed SEC Form 8|K
February 9, 2024 - EX-5.1 - 8-K: Current report filing
We deliver this opinion with respect to certain matters in connection with the sale by Sutro Biopharma, Inc., a Delaware corporation (the “ ...
STRO SEC Filings - Sutro Biopharma, Inc.- Annual Report, Proxy ...
News Filings. 2024-08-13, 8-K, Financial Statements and Exhibits, Results ... UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...
October 4, 2023 - 8-K: Current report filing - Sutro Biopharma, Inc.
UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d) of the ...
Sutro Biopharma, Inc. Files SEC Form 8-K, Current Report: (Jun. 14 ...
Gale OneFile includes Sutro Biopharma, Inc. Files SEC Form 8-K, Current Report: (Jun. 14, 2023). by . Click to explore.
FORM 8-A. FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES. PURSUANT TO SECTION 12(b) OR (g) OF THE. SECURITIES EXCHANGE ACT OF l934. Sutro Biopharma, Inc.
SUTRO BIOPHARMA, INC. Form SC 13G Filed 2023-10-10
Insurance company as defined in Section 3(a)(19) of the Act;. (d). □. Investment company registered under Section 8 of the Investment Company ...
SUTRO BIOPHARMA, INC. - ProxyVote.com
The final results will be tallied by the inspector of elections and filed with the SEC in a Current Report on Form 8-K within four business days ...
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under ...
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
8-K ; SUTRO BIOPHARMA, INC. ; 111 Oyster Point Blvd. ; South San Francisco , California , 94080 ; 650 ) 881-6500.
SUTRO BIOPHARMA, INC. Form 8-K Current Report Filed 2023-01-09
... Company files from time to time with the Securities and Exchange Commission. ... forms filed with the SEC.", "label": "Entity Registrant Name ...
All SEC Filings - Sutro Biopharma, Inc.
8-K, ARS, CERT, CORRESP, CT ORDER, D, D/A, DEF 14A, DEFA14A, DRS, DRS/A, DRSLTR, EFFECT ... Form 424B4: Prospectus filed pursuant to Rule 424(b)(4), 267. 09/27/18 ...
On June 27, 2022, Sutro Biopharma, Inc., a Delaware corporation (the ... Form 8-K and incorporated by reference herein. The corporate presentation will ...
Sutro Biopharma (STRO) SEC Filings & 10K Form - MarketBeat
Date, Filer, Form Type, View. 11/12/2024 8:34 AM, Adage Capital Management, L.P. (Filed by) Sutro Biopharma (Subject), Form SC 13G/A. 11/04/2024
Sutro Biopharma, Inc. (STRO) Stock Price, News, Quote & History
The company develops site-specific and novel-format antibody drug conjugates ... All SEC Filings. Corporate Changes & Voting Matters. Periodic Financial ...
Sutro Biopharma Inc.: Supplemental Prospectus - Form 424B5 ...
09-02-2024: 424B5 Table of Contents As Filed Pursuant to Rule 424(b)(5) Registration No. 333-275525.
Point72 Asset Management, L.P. - SC 13G - April 05, 2024 - Fintel
SCHEDULE 13G. Under the Securities Exchange Act of 1934. (Amendment No. )*. Sutro Biopharma, Inc. (Name of Issuer).
Sutro Biopharma, Inc. (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register (a) ...
All SEC Filings - Sutro Biopharma, Inc.
8-K, ARS, CERT, CORRESP, CT ORDER, D, D/A, DEF 14A, DEFA14A, DRS, DRS/A, DRSLTR, EFFECT ... Form S-1MEF: A new registration statement filed under Rule 462(b) to ...
All SEC Filings - Sutro Biopharma, Inc.
8-K, ARS, CERT, CORRESP, CT ORDER, D, D/A, DEF 14A, DEFA14A, DRS, DRS/A, DRSLTR, EFFECT ... Form 4: Statement of changes in beneficial ownership of securities, 2.
FORM S-1. REGISTRATION STATEMENT. UNDER. THE SECURITIES ACT OF 1933. SUTRO BIOPHARMA, INC. (Exact name of registrant as specified in its charter). Delaware ...